US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

32.55

-0.3131-0.95%

Post-market: 32.55-0.0070-0.02%17:07 EDT

Volume:432

Turnover:14.10K

Market Cap:6.51M

PE:- -

High:32.56

Open:32.56

Low:32.55

Close:32.87

52wk High:43.01

52wk Low:27.40

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.31

T/O Rate:0.22%

Dividend:0.32

Dividend Rate:0.98%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes Reports Positive Phase 1b Proof-of-Concept Data for ALKS 7290 in Adult ADHD

Alkermes -Alks 7290 Generally Well Tolerated at All Doses in Healthy Volunteers and Adults with Adhd

THOMSON REUTERS

Alkermes Announces Positive Phase 1B Results Demonstrating Clinical Proof-of-Concept for Alks 7290 in Adults with Attention-Deficit Hyperactivity Disorder (Adhd)

THOMSON REUTERS

Alkermes - Phase 2 Study of Alks 7290 in Adults with Adhd Enrolling, Data Expected in 2027

THOMSON REUTERS

US Research Roundup-eBay, Sunbelt Rentals, T-Mobile

Scholar Rock Holding Corporation : JP Morgan Raises Target Price to $70 from $63

THOMSON REUTERS

Alkermes Files Form 3 for Director Anne Clem Whitaker`

Dianthus Therapeutics Chief Accounting Officer Edward Carr Disposes of Shares for $2.01 Million

US Stocks-S&P 500, NASDAQ Advance, Turning the Page on a Tumultuous Week

U.S. Small Caps Close Lower; Xenon Pharmaceuticals Posts Biggest Loss

Dianthus files automatic mixed securities shelf

Dianthus Therapeutics Inc: Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)

U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix

Xenon Pharmaceuticals Down over 28%, on Pace for Largest Percent Decrease Since March 2017

Xenon Pharmaceuticals falls -29.8%

U.S. Stocks on the MOVE-CoreWeave, StubHub, Ultragenyx

Sector Update: Healthcare

MT Newswires Live

Xenon Stock Craters on Drug Trial Setback. Its Failure Could be This Rival's Gain.

A Sideways Market and Rising Earnings Are Presenting Opportunities Not Seen Since ChatGPT First Launched

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBRN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":32.552,"timestamp":1790971200000,"preClose":32.8651,"halted":0,"volume":432,"hourTrading":{"tag":"盘后","latestPrice":32.545,"preClose":32.552,"latestTime":"17:07 EDT","volume":10,"amount":323.738,"timestamp":1790975268525,"change":-0.007,"changeRate":-0.000215,"amplitude":0},"delay":0,"changeRate":-0.00952682328670835,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Market Closed","change":-0.3131,"latestTime":"10-02 16:00:00 EDT","open":32.561,"high":32.561,"low":32.545,"amount":14103,"amplitude":0.000487,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.8651,"sharesOutstanding":150000,"nav":32.771593,"aum":6554318.6,"dividendRate":0.00979,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.545,"preClose":32.552,"latestTime":"17:07 EDT","volume":10,"amount":323.738,"timestamp":1790975268525,"change":-0.007,"changeRate":-0.000215,"amplitude":0},"volumeRatio":0.3104039106268791,"impliedVol":0.0726,"impliedVolPercentile":0.3187},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3104039106268791,"shares":200000,"dividePrice":0.3187,"high":32.561,"amplitude":0.000487,"preClose":32.8651,"low":32.545,"week52Low":27.4025,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":32.552,"eps":0,"divideRate":0.00979,"volume":432,"delay":0,"ttmEps":0,"open":32.561,"prevYearClose":32.3193,"prevWeekClose":33.3342,"prevMonthClose":33.265,"prevQuarterClose":33.265,"fiveDayClose":33.3342,"twentyDayClose":39.3744,"sixtyDayClose":40.2891},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669415062","title":"Alkermes Reports Positive Phase 1b Proof-of-Concept Data for ALKS 7290 in Adult ADHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2669415062","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669415062?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:01","pubTimestamp":1789988517,"startTime":"0","endTime":"0","summary":"Alkermes reports positive Phase 1b proof-of-concept data for ALKS 7290 in adult ADHDAlkermes reported positive Phase 1b topline results for ALKS 7290 in adults with ADHD; results have already been pre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL2WW99h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","MEDX","FBT","BK4139","PSIL","IBRN","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669505181","title":"Alkermes -Alks 7290 Generally Well Tolerated at All Doses in Healthy Volunteers and Adults with Adhd","url":"https://stock-news.laohu8.com/highlight/detail?id=2669505181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669505181?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9RZ6JR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","BK4139","PSIL","PSCH","IBRN","FBT","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150548","title":"Alkermes Announces Positive Phase 1B Results Demonstrating Clinical Proof-of-Concept for Alks 7290 in Adults with Attention-Deficit Hyperactivity Disorder (Adhd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150548?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9RZ6JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","ALKS","IBRN","FBT","PSCH","MEDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150512","title":"Alkermes - Phase 2 Study of Alks 7290 in Adults with Adhd Enrolling, Data Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150512?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9RZ6JR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","MEDX","BK4139","IBRN","PSIL","FBT","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669155576","title":"US Research Roundup-eBay, Sunbelt Rentals, T-Mobile","url":"https://stock-news.laohu8.com/highlight/detail?id=2669155576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669155576?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:41","pubTimestamp":1789976490,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-eBay, Sunbelt Rentals, T-MobileSept 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including eBay, Sunbelt Ren","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","OKTX","STBQ","PAGP","EWTX","PAA","BK4528","AMRZ","AIRR","AMLP","ARHS","LU2095319765.USD","TTMX","SRRK","BUG","FOUR","SUNB","BKH","EMLP","LU2322448957.HKD","PKB","CL","HAKY","IQMX","ONLN","EBAY","TTMI","GOSS","OKTA","THO","AMZA","SPAM","LU0109394709.USD","THNR","CDW","PSWD","LU1064131342.USD","IBRN","TMUS","CLIX","IHAK","MLPA","OKTG","BK4504","BLSM","MTZ","LU0251131958.USD","NBIX","HUBS","MCHB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669132568","title":"Scholar Rock Holding Corporation : JP Morgan Raises Target Price to $70 from $63","url":"https://stock-news.laohu8.com/highlight/detail?id=2669132568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669132568?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:29","pubTimestamp":1789964962,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","SRRK","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668789973","title":"Alkermes Files Form 3 for Director Anne Clem Whitaker`","url":"https://stock-news.laohu8.com/highlight/detail?id=2668789973","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668789973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:48","pubTimestamp":1789764537,"startTime":"0","endTime":"0","summary":"Alkermes files Form 3 for director Anne Clem Whitaker`Alkermes director Anne Clem Whitaker filed a Form 3 initial statement of beneficial ownership dated Sept. 14, 2026.Disclaimer:This news brief was ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL7wyxYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","PSIL","BK4139","PSCH","IBRN","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973172","title":"Dianthus Therapeutics Chief Accounting Officer Edward Carr Disposes of Shares for $2.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973172","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973172?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:37","pubTimestamp":1789763825,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Chief Accounting Officer Edward Carr disposes of shares for $2.01 millionDianthus Therapeutics reported Chief Accounting Officer Edward Carr exercised stock options for 20,000 sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL6j4XMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics Chief Accounting Officer Edward Carr Disposes of Shares for $2.01 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668097355","title":"US Stocks-S&P 500, NASDAQ Advance, Turning the Page on a Tumultuous Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2668097355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668097355?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:20","pubTimestamp":1789762837,"startTime":"0","endTime":"0","summary":"US STOCKS-S&P 500, Nasdaq advance, turning the page on a tumultuous weekNEW YORK, Sept 18 (Reuters)-Wall Street closed a volatile week on a muted note on Friday as benchmark US Treasury yields topped ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A15E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SBIO","XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973504","title":"U.S. Small Caps Close Lower; Xenon Pharmaceuticals Posts Biggest Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973504?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:20","pubTimestamp":1789762800,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies fell Friday, as the Russell 2000 Index declined 0.5%, and the S&P Small Cap 600 Index was down 0.5%.Among companies with a market value of $1 billion to $6.7 billion, Xenon Pharmaceuticals Inc. was the biggest laggard during the session, dropping 31%, followed by shares of Genius Sports Ltd., which dropped 13%. Shares of NuScale Power Corp. dropped 8.5%, SL Science Holding Ltd. shares tumbled 8.0%, and Rush Street Interactive Inc. plunged 7.7%.Securitize Corp. was the best performer, surging 22%, followed by Bitdeer Technologies Group, which jumped 15%. MARA Holdings Inc. shares jumped 14%, Sharplink Inc. surged 13%, and shares of Sigma Lithium Corp. surged 12%.Major U.S. stock indexes ended Friday mixed as the Nasdaq Composite Index added 0.4%. Meanwhile, the S&P 500 Index added 0.2%, and the Dow Jones Industrial Average fell 0.2%.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRN","XENE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668536973","title":"Dianthus files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2668536973","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668536973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761909,"startTime":"0","endTime":"0","summary":"16:03 EDT Dianthus (DNTH) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668978775","title":"Dianthus Therapeutics Inc: Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978775?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:03","pubTimestamp":1789761798,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nFWN45A0JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668273689","title":"Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668273689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668273689?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:30","pubTimestamp":1789749010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corcept Therapeutics (CORT) and Xenon (XENE) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","BK4139","PSCH","HCSG","SBIO","LU1559883803.SGD","BK4588","CORT","XLV","BK4581","BK4585","FBT","XENE","BK4137","LABU","BK4532","BK4007","LU0566484027.USD","XBI","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668922682","title":"U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2668922682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668922682?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:52","pubTimestamp":1789746775,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Halozyme Therapeutics, Etsy, NetflixSeptember 18 (Reuters)-Wall Street's main indexes fell on Friday in the final stretch of a turbulent week, as investors assessed shifti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","STUB","TRGP","SGDM","CRWV","LU0154245673.USD","NEMG","XENE","UMI","MLPX","TRUM","CRWU","ETSY","AGMI","FFOX","NEM","PXI","LU0278409577.USD","AUAU","CRWX","AFK","CWVX","BK4209","GLDN","LU2361045086.USD","SLX","CORD","GDX","MLPI","FMTL","SLVP","LU1223082519.USD","CAVA","TPZ","STLD","AUMI","CRWG","AU","HALO","GDMN","PYZ","BK4570","LU0788108826.HKD","NUE","CWII","NWMX","DSP","DT","IBRN","PICK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668771921","title":"Xenon Pharmaceuticals Down over 28%, on Pace for Largest Percent Decrease Since March 2017","url":"https://stock-news.laohu8.com/highlight/detail?id=2668771921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668771921?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:41","pubTimestamp":1789742460,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc.  is currently at $41.09, down $16.26 or 28.35%--Would be lowest close since Feb. 5, 2026, when it closed at $40.39--On pace for largest percent decrease since March 24, 2017, when it fell 52.79%--Snaps a two-day winning streak--Down 29.94% this week; worst weekly performance since the week ending March 24, 2017, when it fell 42.59%--Down 31.77% month-to-date--Down 8.32% year-to-date--Down 42.09% from its all-time closing high of $70.96 on July 9, 2026--Up 11.2% from 52 weeks ago , when it closed at $36.95--Down 42.09% from its 52-week closing high of $70.96 on July 9, 2026--Up 12.51% from its 52-week closing low of $36.52 on Sept. 25, 2025--Traded as low as $39.83; lowest intraday level since Jan. 20, 2026, when it hit $39.29--Down 30.55% at today's intraday low; largest intraday percent decrease since March 24, 2017, when it fell as much as 56.35%All data as of 10:38:06 AM ETSource: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","XENE","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668600921","title":"Xenon Pharmaceuticals falls -29.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668600921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668600921?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:05","pubTimestamp":1789740325,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals (XENE) is down -29.8%, or -$17.08 to $40.27. Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-falls-29-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-falls-29-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBRN","XENE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668573926","title":"U.S. Stocks on the MOVE-CoreWeave, StubHub, Ultragenyx","url":"https://stock-news.laohu8.com/highlight/detail?id=2668573926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668573926?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:04","pubTimestamp":1789736682,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-CoreWeave, StubHub, UltragenyxSeptember 18 (Reuters)-The major US stock indexes were set for a subdued open on Friday, as lower oil prices and higher Treasury yields sent ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1102505929.USD","LU0788108826.HKD","LU0210533765.USD","LU0456854461.SGD","LU0368265764.SGD","BK4598","LU0300736062.USD","CORD","LU0256863811.USD","LU0082616367.USD","LU0079474960.USD","SLVP","GDMN","LU2237957811.SGD","FMTL","LU0642271901.SGD","LU0300736492.USD","LU0786609619.USD","LU2361044865.SGD","BK4581","LU2361045086.USD","IE00BQXX3D17.EUR","MLPX","LU0788109394.HKD","LU0203202063.USD","LU2362540622.SGD","RARE","IE00B19Z3581.USD","LU2361044949.HKD","LU0788109121.HKD","IE00BQXX3F31.USD","SG9999004303.SGD","BK4551","SGXZ51526630.SGD","SGXZ99366536.SGD","IE00B19Z3B42.SGD","LU0353189763.USD","LU2552382215.SGD","LU0640476718.USD","XENE","IE00BKDWB100.SGD","BK4588","BK4023","LU0210536198.USD","BK4192","BK4533","LU0612318971.USD","LU2362541273.HKD","CRWV","LU1223083913.SGD","NFX","LU1435385759.SGD","LU1102505762.USD","LU0630314457.HKD","LU0198837287.USD","LU2552382058.USD","GFI","NEM","NFLY","LU0266512473.USD","STUB","LU0330918003.SGD","SNFLXmain","LU0203201768.USD","LU2237957902.USD","LU1127390331.HKD","LU1778281490.HKD","LU1429558221.USD","SG9999001143.SGD","LU2362541513.USD","BK4527","LU0170899867.USD","LU0215105999.USD","LU2462611646.USD","HMY","LU0708995401.HKD","LU1868837565.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","IE00B19Z8X17.USD","LU0654597011.USD","BK4108","IE00BQXX3C00.GBP","LU2498475776.HKD","LU0303821028.USD","LU0075056555.USD","LU1069344957.HKD","LU2860962120.EUR","BK4548","TPZ","SGDM","LU0122376428.USD","CWVX","TRUM","BK4116","BK4507","LU0498741890.SGD","LU1674673691.USD","LU0234572021.USD","IE0002270589.USD","LU1989764664.SGD","GDX","CWII","LU0868494617.USD","LU0942090050.USD","LU0143863198.USD","IE00BWXC8680.SGD","NEMG","LU1430597077.USD","LU2449327464.USD","LU0672654240.SGD","LU2087625088.SGD","NWMX","LU0055631609.USD","LU0109391861.USD","LU1720051108.HKD","LU0345780950.USD","LU2896262040.SGD","XLC","CRWU","LU0234570918.USD","NFLP","AUAU","BK4522","LU0256863902.USD","LU2108987350.USD","LU0477156953.USD","MLPI","NFLU","BUZZ","LU1674673428.USD","NFLW","LU1366192091.USD","SGXZ81514606.USD","AU","LU0345781412.USD","LU0130102774.USD","LU0417517546.SGD","BK4122","LU1235294995.USD","LU0127658192.USD","LU0612318385.USD","LU1720051017.SGD","IE00BKVL7J92.USD","LU0303823156.USD","IE00BKPKM429.USD","LU1223082196.USD","LU1861559042.SGD","LU2552382132.HKD","NFLX","LU1023059493.AUD","LU0106261372.USD","GXPC","IE00BZ1G4Q59.USD","BK4534","LU0345780281.USD","LU2326559502.SGD","SGXZ23171101.USD","UMI","LU1979441026.SGD","LU0278409577.USD","DSP","LU1548497426.USD","LU1883866441.USD","TRGP","CRWG","GLDN","LU0719512351.SGD","LU0006306889.USD","LU0368265418.SGD","IBRN","LU1064131342.USD","GOAU","AUMI","PXI","BK4144","BK4585","FCOM","LU1267930730.SGD","LU1823568750.SGD","LU1861558580.USD","LU2357305700.SGD","LU0345780521.USD","LU0496367417.USD","LU0130517989.USD","LU1232071149.USD","IE00B19Z9505.USD","IE00B19Z8W00.USD","LU2264538146.SGD","LU0143863784.USD","LU1280957306.USD","LU0498741114.HKD","LU0266512127.USD","BK4566","CRWX","LU0882574139.USD","BK4017","BK4524","LU0648001328.SGD","LU2543165471.USD","IE00B1XK9C88.USD","LU0724618789.USD","LU0868494708.USD","LU1035775433.USD","LU0980610538.SGD","LU0097036916.USD","ETSY","BK4570","BK4220","AGMI","LU1988902786.USD","LU1223082519.USD","LU0054578231.USD","LU0077335932.USD","NFXL","LU1868838027.USD","LU1201861249.SGD","LU2461242641.AUD","BK4532","BK4587","LU1046421795.USD","LU0353189680.USD","BK4139","NFXS","AFK","LU1316542783.SGD","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668268259","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668268259","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668268259?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:59","pubTimestamp":1789736375,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to lower pre-bell Friday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down 0.4%.Xenon Pharmaceuticals  shares were down more than 23% after the company voluntarily paused enrollment of new patients in studies for major depressive disorder and bipolar depression.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BGHQF748.EUR","LU1894683264.USD","BK4137","LU0061475181.USD","XLV","IE00B64PRP62.GBP","BK4588","LABU","STT","XBI","LU0029874061.USD","LU1894683348.USD","BK4139","IE00B3QW5Z07.USD","BK4135","LU1883839398.USD","IBB","LU0128526141.USD","IE0034235188.USD","BK4581","XENE","FDN","SBIO","BK4550","BK4585","HCSG","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668925728","title":"Xenon Stock Craters on Drug Trial Setback. Its Failure Could be This Rival's Gain.","url":"https://stock-news.laohu8.com/highlight/detail?id=2668925728","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668925728?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:48","pubTimestamp":1789735680,"startTime":"0","endTime":"0","summary":"What should have been a milestone for Xenon Pharmaceuticals was quickly derailed by a clinical setback-and one that could prove a windfall for a similarly pressured rival.Xenon said late Thursday that","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BK4139","LU1093756168.USD","BHVN","IBRN","XENE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668947223","title":"A Sideways Market and Rising Earnings Are Presenting Opportunities Not Seen Since ChatGPT First Launched","url":"https://stock-news.laohu8.com/highlight/detail?id=2668947223","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668947223?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:30","pubTimestamp":1789734600,"startTime":"0","endTime":"0","summary":"A reset for technology makes the sector more attractive relative to the market, says Truist.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPXU","FEBU","JOYT","IYF","BRKL","PMDE","VGFPF","LU0234570918.USD","IVV","SH","BRKD","LU2168564222.USD","LU0251142724.SGD","FNCL","RGLO","GXDW","07777","DFNL","UPRO","LU1363072403.SGD","IYG","SPYU","TRUF","LU0417517546.SGD","SSO","BRKU","LU0187121727.USD","MMAX","SBIO","BK4176","LU0048573561.USD","SDS","SPDN","LU0170899867.USD","LU2168564149.EUR","TSPA","CDIG","LU2168564065.EUR","BRKW","BKLC",".DJI","BRKC","LU1074936037.SGD","YSPY","SPUU","PTLC","SPY","SPYM",".IXIC","TACU","VOTE","IBRN","SPYQ","09777",".SPX","LU0053666078.USD","SPXL","IE000M9KFDE8.USD","SPXS","UYG","VOO","LU0130102774.USD","IXG","VFH","SPYH","DECU","DMAX","HIBL","SMAX","HK0000914686.HKD","XLF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}